Editorial Collaborators

Abstract

Chul Ahn, U. of Texas Southwestern Medical Center * Mouna Akacha, Novartis Pharma AG Zoran Antonijevic, Z-Adaptive Design Koko Asakura, Natl Cerebral and Cardiovascular Ctr Elande Baro, FDA * Emel Basar, Statistics * Cynthia Basu, Pfizer Inc Mohamed Amine Bayar Iount Bebu, The George Washington U. * Erik Bloomquist * Jack Bowden, U. of Bristol Thomas Brechenmacher Per Brockhoff, Technical U. of Denmark Matthias Brueckner, U. Bremen Richard Burdick, Elion Labs * Thomas Burnett, Lancaster U. Guy Cafri, UCSD Andrea Callegaro, GSK Vaccines Marinela Capanu, Memorial Sloan Kettering Cancer Ctr * Arunava Chakra Dung-Tsa Chen, Moffitt Cancer Ctr and Research Inst Ray-Bing Chen, National Cheng Kung U. * Yansong Cheng, Boston U. Cody Chiuzan, Columbia U. Evgeny Degtyarev * Eugene Demidenko, Dartmouth College * Guoqing Diao, George Mason U. * Gaohong Dong, iStats Inc. * Pang Du, Virginia Tech * Chunpeng Fan, Sanofi US Inc. Laura Fernandes Christine Fletcher, Amgen Ltd Tim Friede, U. Göttingen Byron Gajewski, U. of Kansas Medical Center Paul Gallo, Novartis Margaret Gamalo, Eli Lilly & Company * Steven Gilbert, Pfizer Pharma Therapeutics Clinical R&D Dan Gillen, U. of California Irvine * Ekkehard Glimm, Novartis Pharma AG Heiko Goette, Merck KGaA Guadalupe Gomez, U/Politécnica de Catalunya Jiangtao Gou, Villanova U. Stella Grosser, FDA * Olivier Guilbaud, (Retired from AstraZeneca) * Toshimitsu Hamasaki, George Washington U. Biostatistics Center * Lisa Hampson, Lancaster U. Frank Harrell, Vanderbilt U. * Pei He, Genentech Inc * Shanjun Helian Rob Hemmings, Consilium Martin Ho, CDRH/FDA Brian Hobbs Chin-Fu Hsiao, Natl Health Research Inst Mufeng Hu, Syneos Health * Xuelin Huang, U. of Texas, MD Anderson Cancer Ctr Kimitoshi Ikeda Christopher Jennison, U. of Bath Yuan Ji, The U. of Chicago * Liyi Jia, Merck and Co Inc * Oliver Keene Yang-Jin Kim, Sookmyung Women’s U. Yoonhee Kim, FDA Florian Klinglmueller, Medical U. of Vienna Masha Kocherginsky John Kolassa, Rutgers U. George Kordzakhia Andrzej Kosinski Mark Krailo Johannes Krisam, Ruprecht Karls U. Heidelberg * Yu Lan, Sanofi Catherine Lesko, Johns Hopkins Bloomberg School of Public Health Jerry Li Qing Li, MercK Research Labs * Wen Li, Merck * Xiaoming Li, Gilead * Jason Liao, Merck & Co., Inc Lifeng Lin, Florida State U. Ray Lin, Genentech/Roche Ruitao Lin, The U. of Texas MD Anderson Cancer Ctr Kenneth Liu, Merck Xiaobin Liu, U. at Buffalo Yimeng Liu, U. of Pittsburgh Brent Logan Lais Loose * Tianmeng Lyu, Novartis Dominic Magirr, Lancaster U. Arnab Maity Craig Mallinckrodt, Biogen * Devan Mehrotra, Merck Research Labs Michael Meyners, Procter & Gamble Service GmbH * Johanna Mielke, Novartis Pharma AG Tobias Mielke * Frank Miller, Stockholm Univ David Ohlssen, Novartis Pharmaceuticals Corp Alexis Oliva, U. La Laguna Lei Pang, Merck Eunsik Park, Chonnam National U. Scott Patterson, Sanofi Pasteur Inna Perevozskaya, Glaxo SmithKline * Thomas Permutt, FDA Frank Pétavy, European Medicines Agency * José Pinheiro, Johnson and Johnson Elena Polverejan, Janssen Pharmaceuticals Inc Wenji Pu * Li Qi, Sanofi-Aventis US LLC * Russell Reeve, Quintiles * Kaspar Rufibach, F. Hoffmann-La Roche Estelle Russek-Cohen, FDA Office of the Chief Scientist Matilde Sanchez-Kam, SanchezKam LLC